GSE67980 | GSM1660147 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr9.1.2 | lineage-confirmed PCa CTC CRPC enzalutamide-naive (Group A) | donor: Pr9; donor type: CRPC; enzalutamide: enzalutamide-naive (Group A) |
GSE69405 | GSM1702695 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC28 | PDX, LC-PT-45-Re | cell type: PDX |
GSE70580 | GSM1810650 | Illumina HiSeq 2000 | Homo sapiens | T75_P1_H3_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
GSE70580 | GSM1810906 | Illumina HiSeq 2000 | Homo sapiens | T86_P1_F10_ILC3 | Donor T86-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T86; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
GSE71318 | GSM1833298 | Illumina HiSeq 2500 | Homo sapiens | 8cell_#1_B | human 8 cell | cell type: 8 cell |
GSE72056 | GSM1850720 | Illumina NextSeq 500 | Homo sapiens | Cy71_CD45_B03_S495_comb | melanoma | tumor-of-origin: Cy71 |
GSE72056 | GSM1850976 | Illumina NextSeq 500 | Homo sapiens | Cy74_CD45_C08_S416_comb | T-cell | tumor-of-origin: Cy74 |
GSE72056 | GSM1851232 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-neg-PDL1-neg-AS-C4-R1-H01-S181-comb | melanoma | tumor-of-origin: cy79 |
GSE72056 | GSM1851488 | Illumina NextSeq 500 | Homo sapiens | cy79-p3-CD45-pos-PD1-pos-AS-C2-R1-A12-S396-comb | T-cell | tumor-of-origin: cy79 |
GSE72056 | GSM1851744 | Illumina NextSeq 500 | Homo sapiens | cy79-p4-CD45-neg-PDL1-neg-H10-S1150-comb | melanoma | tumor-of-origin: cy79 |